What is a suitable alternative Selective Serotonin Reuptake Inhibitor (SSRI) to switch to from Lexapro (escitalopram) 20mg for anxiety?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Switching from Lexapro 20mg to Another SSRI for Anxiety

When switching from Lexapro (escitalopram) 20mg to another SSRI for anxiety, sertraline is the recommended alternative due to its established efficacy in anxiety disorders, favorable side effect profile, and lower potential for drug interactions compared to other SSRIs.

Rationale for Switching from Escitalopram

Escitalopram is a highly selective SSRI with established efficacy for anxiety disorders 1. However, there are several reasons why switching to another SSRI might be necessary:

  • Inadequate response to maximum dose (20mg)
  • Intolerable side effects (common with escitalopram: nausea, diarrhea, sexual dysfunction)
  • Drug interactions concerns
  • Insurance/formulary issues

Best Alternative SSRI Options

Sertraline (First Choice)

  • Starting dose: 25-50mg daily
  • Target dose: 50-200mg daily
  • Key advantages:
    • Low potential for drug interactions compared to other SSRIs 2
    • Well-established efficacy for multiple anxiety disorders 3
    • Better tolerated in many patients compared to escitalopram
    • Less likely to cause discontinuation syndrome than paroxetine or fluvoxamine 3

Fluoxetine (Alternative Option)

  • Starting dose: 10-20mg daily
  • Target dose: 20-80mg daily
  • Key advantages:
    • Longer half-life (reduces discontinuation symptoms)
    • Established efficacy in anxiety disorders
    • May be better for patients who experience breakthrough anxiety between doses

Cross-Titration Protocol

  1. Week 1: Reduce escitalopram to 10mg while starting sertraline at 25mg
  2. Week 2: Reduce escitalopram to 5mg while increasing sertraline to 50mg
  3. Week 3: Discontinue escitalopram and adjust sertraline dose as needed (50-100mg)
  4. Weeks 4-6: Titrate sertraline to optimal dose (typically 50-200mg)

Important Considerations

Potential Adverse Effects to Monitor

  • Initial anxiety/agitation (may be advisable to start with a subtherapeutic "test" dose) 3
  • Gastrointestinal effects (nausea, diarrhea)
  • Sleep disturbances
  • Sexual dysfunction
  • Risk of serotonin syndrome during cross-titration

Cautions

  • Avoid abrupt discontinuation of escitalopram to prevent withdrawal symptoms 1
  • Monitor closely during first 24-48 hours after combining medications for signs of serotonin syndrome 3
  • Absolutely avoid MAOIs during this transition and for 2 weeks after stopping either medication 3

Special Considerations

  • QT prolongation: If this was a concern with escitalopram, sertraline has less impact on QT interval 3
  • Drug interactions: Sertraline has fewer CYP450 interactions than many other SSRIs 2
  • Discontinuation syndrome: Sertraline has moderate risk (less than paroxetine, more than fluoxetine) 3

Expected Timeline for Response

  • Initial response: 2-4 weeks
  • Maximal response: 8-12 weeks
  • Continue treatment for at least 6-12 months after remission to prevent relapse 4

Common Pitfalls to Avoid

  • Switching too quickly between medications
  • Not accounting for the different half-lives of SSRIs
  • Failing to monitor for serotonin syndrome during cross-titration
  • Not providing adequate patient education about potential temporary increase in anxiety during transition

Remember that while sertraline is generally the best alternative to escitalopram for anxiety, individual response varies. Close monitoring during the transition period is essential to ensure optimal outcomes and minimize adverse effects.

References

Guideline

Escitalopram Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.